Cargando…
Recent advances in the diagnosis and management of primary myelofibrosis
Primary myelofibrosis (PMF) is a myeloproliferative neoplasm (MPN) in which dysregulation of the Janus kinase/signal transducers and activators of transcription (JAK/STAT) signaling pathways is the major pathogenic mechanism. Most patients with PMF carry a driver mutation in the JAK2, MPL (myeloprol...
Autores principales: | Takenaka, Katsuto, Shimoda, Kazuya, Akashi, Koichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Internal Medicine
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030412/ https://www.ncbi.nlm.nih.gov/pubmed/29665657 http://dx.doi.org/10.3904/kjim.2018.033 |
Ejemplares similares
-
Recent advances in therapies for primary myelofibrosis
por: Vainchenker, William, et al.
Publicado: (2023) -
Fibrocytes in primary myelofibrosis
por: Shimoda, Kazuya, et al.
Publicado: (2021) -
Recent advances in understanding myelofibrosis and essential thrombocythemia
por: Vainchenker, William, et al.
Publicado: (2016) -
Nationwide prospective survey of secondary myelofibrosis in Japan: superiority of DIPSS-plus to MYSEC-PM as a survival risk model
por: Shide, Kotaro, et al.
Publicado: (2023) -
Recurrent Subcutaneous Sweet's Disease in a Myelofibrosis Patient Treated with Ruxolitinib before Allogeneic Stem Cell Transplantation
por: Sakoda, Teppei, et al.
Publicado: (2017)